Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

Joining us is the company Sanofi and Regeneron to talk to us more about COPD also known as Chronic Obstructive Pulmonary ...

Dupixent is an “add-on” drug for COPD, meaning patients take it in addition to inhaled medication Dupixent isn’t approved as a stand-alone treatment for COPD. The U.S. Food and Drug ...

Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an ...

The US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment of adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and ...

The drug, Dupixent, is the first biologic medicine approved in the U.S. for the treatment of COPD, a respiratory disease that restricts airflow and damages the lungs. The treatment showed a ...

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils ... U.S. INDICATIONS DUPIXENT is a prescription medicine used: to treat adults and children 6 months ...

Dr MeiLan Han, a Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan Health, discusses the impact inadequately controlled COPD has on daily ...

Dupixent for the treatment of COPD has been approved in more than 30 ... our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments ...

Complex, nationwide analysis included both social and environmental factors and could inform local and national policy.

Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an ...